Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Sees Large Decrease in Short Interest

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) saw a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 28,900 shares, a decline of 30.9% from the September 15th total of 41,800 shares. Based on an average daily trading volume, of 36,000 shares, the days-to-cover ratio is presently 0.8 days. Based on an average daily trading volume, of 36,000 shares, the days-to-cover ratio is presently 0.8 days.

Conduit Pharmaceuticals Trading Down 6.5%

Shares of CDTTW opened at $0.01 on Friday. The stock has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.01. Conduit Pharmaceuticals has a 52-week low of $0.01 and a 52-week high of $0.02.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.